Takeda Completes Consumer Health Split

Feb 20, 2017

Takeda Pharmaceutical Company will transfer its Japan consumer healthcare business unit to Takeda Consumer Healthcare Company Limited (TCHC), its wholly owned subsidiary.

Takeda announced its intention to spin-off its Japan Consumer Healthcare Business Unit in February 2016, in order to realize a more agile business model to promptly meet environmental changes and customers’ needs in the consumer healthcare market.

The Japan consumer healthcare business unit has been focusing on over-the counter medicines including Alinamin and Benza, and a health food named Midori-no-Shukan.

Read the Takeda press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments